Efficacy of Cardiac Resynchronization Therapy Using Automated Dynamic Optimization and Left Ventricular-only Pacing

Background Although device-based optimization has been developed to overcome the limitations of conventional optimization methods in cardiac resynchronization therapy (CRT), few real-world data supports the results of clinical trials that showed the efficacy of automatic optimization algorithms. We investigated whether CRT using the adaptive CRT algorithm is comparable to non-adaptive biventricular (BiV) pacing optimized with electrocardiogram or echocardiography-based methods. Methods Consecutive 155 CRT patients were categorized into 3 groups according to the optimization methods: non-adaptive BiV (n = 129), adaptive BiV (n = 11), and adaptive left ventricular (LV) pacing (n = 15) groups. Additionally, a subgroup of patients (n = 59) with normal PR interval and left bundle branch block (LBBB) was selected from the non-adaptive BiV group. The primary outcomes included cardiac death, heart transplantation, LV assist device implantation, and heart failure admission. Secondary outcomes were electromechanical reverse remodeling and responder rates at 6 months after CRT. Results During a median 27.5-month follow-up, there was no significant difference in primary outcomes among the 3 groups. However, there was a trend toward better outcomes in the adaptive LV group compared to the other groups. In a more rigorous comparisons among the patients with normal PR interval and LBBB, similar patterns were still observed. Conclusion In our first Asian-Pacific real-world data, automated dynamic CRT optimization showed comparable efficacy to conventional methods regarding clinical outcomes and electromechanical remodeling.

[1]  D. Birnie,et al.  Adaptive cardiac resynchronization therapy is associated with decreased risk of incident atrial fibrillation compared to standard biventricular pacing: A real-world analysis of 37,450 patients followed by remote monitoring. , 2019, Heart rhythm.

[2]  M. Cho,et al.  Prognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart Failure , 2019, Journal of Korean medical science.

[3]  C. Pappone,et al.  Programming Cardiac Resynchronization Therapy for Electrical Synchrony: Reaching Beyond Left Bundle Branch Block and Left Ventricular Activation Delay , 2018, Journal of the American Heart Association.

[4]  Jae‐Hyeong Park,et al.  Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: a multicentre, retrospective analysis over a 15-year period in South Korea , 2018, BMJ Open.

[5]  David O. Martin,et al.  Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial. , 2017, Heart rhythm.

[6]  K. Aonuma,et al.  Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter? , 2017, International journal of cardiology.

[7]  Seung‐Jung Park,et al.  Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy , 2017, Yonsei medical journal.

[8]  R. Klepfer,et al.  Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLÉ CRT) study. , 2017, Heart rhythm.

[9]  Deborah H. Kwon,et al.  Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. , 2016, Heart rhythm.

[10]  W. Shimizu,et al.  Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. , 2016, European heart journal.

[11]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[12]  L. Lund,et al.  Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure , 2016, Heart.

[13]  David O. Martin,et al.  Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial. , 2015, JACC. Heart failure.

[14]  Jagmeet P. Singh,et al.  Clinical response with adaptive CRT algorithm compared with CRT with echocardiography-optimized atrioventricular delay: a retrospective analysis of multicentre trials. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  David O. Martin,et al.  Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial. , 2013, Heart rhythm.

[16]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[17]  M. Gold,et al.  The role of AV and VV optimization for CRT , 2013 .

[18]  John Gorcsan,et al.  Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. , 2012, Heart rhythm.

[19]  Luigi Padeletti,et al.  A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  Jagmeet P. Singh,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Heart rhythm.

[21]  David Martin,et al.  A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial. , 2012, American heart journal.

[22]  P. Heidenreich,et al.  Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. , 2011, Heart rhythm.

[23]  David G Strauss,et al.  Defining left bundle branch block in the era of cardiac resynchronization therapy. , 2011, The American journal of cardiology.

[24]  Suneet Mittal,et al.  Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchron , 2010, Circulation.

[25]  Manish S. Gupta,et al.  Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. , 2010, American heart journal.

[26]  Y. Rudy,et al.  RV electrical activation in heart failure during right, left, and biventricular pacing. , 2010, JACC. Cardiovascular imaging.

[27]  N. Freemantle,et al.  Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub‐analysis of the CARE‐HF trial , 2009, European journal of heart failure.

[28]  Wilfried Mullens,et al.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. , 2009, Journal of the American College of Cardiology.

[29]  J. Kirkpatrick,et al.  Ethnic and racial disparities in cardiac resynchronization therapy. , 2009, Heart rhythm.

[30]  Manish S. Gupta,et al.  Optimization of AV and VV Delays in the Real‐World CRT Patient Population: An International Survey on Current Clinical Practice , 2009, Pacing and clinical electrophysiology : PACE.

[31]  S. A. Christman,et al.  Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? , 2009, Journal of the American College of Cardiology.

[32]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[33]  Randy Martin,et al.  Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[34]  C. Lau,et al.  Avoidance of Right Ventricular Pacing in Cardiac Resynchronization Therapy Improves Right Ventricular Hemodynamics in Heart Failure Patients , 2007, Journal of cardiovascular electrophysiology.

[35]  Jiang Ding,et al.  A Prospective Comparison of AV Delay Programming Methods for Hemodynamic Optimization during Cardiac Resynchronization Therapy , 2007, Journal of cardiovascular electrophysiology.

[36]  N. Pijls,et al.  The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. , 2005, Journal of the American College of Cardiology.

[37]  J. Daubert,et al.  Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. , 2005, Journal of the American College of Cardiology.

[38]  A. Waggoner,et al.  Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. , 2004, Heart rhythm.

[39]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[40]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[41]  Andrew P. Kramer,et al.  Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. , 2001, Journal of the American College of Cardiology.

[42]  AngeloAuricchio,et al.  Effect of Pacing Chamber and Atrioventricular Delay on Acute Systolic Function of Paced Patients With Congestive Heart Failure , 1999 .

[43]  C. H. Chen,et al.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. , 1999, Circulation.

[44]  P. Ponikowski,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016 .

[45]  Kevin Vernooy,et al.  Left ventricular lead placement in the latest activated region guided by coronary venous electroanatomic mapping. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[46]  J. Nielsen,et al.  ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .

[47]  J. Day,et al.  Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial. , 2012, Heart rhythm.

[48]  Wan Azman Wan Ahmad,et al.  Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). , 2012, Journal of cardiac failure.